Skip to main content

Table 5 Baseline information and in-hospital mortality

From: Efficacy of oseltamivir-peramivir combination therapy compared to oseltamivir monotherapy for Influenza A (H7N9) infection: a retrospective study

Patients

Characteristics

O+P group

O group

P value

all patients included in the study n = 82

n = 39

n = 43

 
 

Age (years): mean (SD)

56.51(13.86)

59.74(14.71)

0.53

 

No. of male (%)

27(69.23 %)

29(67.44 %)

1.0

 

Time from symptom onset to NAIs administration (days):median(IQR)

7.00(5.00,8.00)

5.00(4.00,7.00)

0.16

 

APACHE II score: mean(SD)

19.05(8.41)

21.09(8.33)

0.86

 

Viral load(log10 /ul) at day 0: median(IQR)

3.34(3.06, 4.45)

3.53(2.84, 5.07)

0.08

 

Mortality(%)

17(43.59)

11(25.58)

0.11

  1. O oseltamivir monotherapy, O+P oseltamivir-peramivir combination therapy, IQR interquartile range, percentile 25 – percentile75